A Oneindia Venture

Shares in Natco Rally On Hepatitis Approval

Shares in Natco rallied after the company received an approval for generic Hepatitis C medicine. The stock was up over 5 per cent at Rs 1,963 on the National Stock Exchange.

Shares in Natco Rally On Hepatitis Approval
It also hit a new 52-week high of Rs 1984 in intra day trading.

"Natco Pharma is pleased to announce that it is the 1st company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India)," the company said in a press release.

GoodReturns.in

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+